Does OBINUTUZUMAB Cause Lethargy? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Lethargy have been filed in association with OBINUTUZUMAB (Gazyva). This represents 0.2% of all adverse event reports for OBINUTUZUMAB.
22
Reports of Lethargy with OBINUTUZUMAB
0.2%
of all OBINUTUZUMAB reports
0
Deaths
15
Hospitalizations
How Dangerous Is Lethargy From OBINUTUZUMAB?
Of the 22 reports, 15 (68.2%) required hospitalization, and 1 (4.5%) were considered life-threatening.
Is Lethargy Listed in the Official Label?
Yes, Lethargy is listed as a known adverse reaction in the official FDA drug label for OBINUTUZUMAB.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Lethargy?
DULOXETINE (1,682)
ADALIMUMAB (828)
LENALIDOMIDE (585)
METHOTREXATE (563)
GABAPENTIN (496)
AMLODIPINE (466)
TREPROSTINIL (460)
OXYCODONE (452)
MORPHINE (445)
LEVOTHYROXINE (419)
Which OBINUTUZUMAB Alternatives Have Lower Lethargy Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE